Ander Mayor Ibarguren

7PUBLICATIONS
40CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medicinal and biomolecular chemistry not elsewhere classifiedTraditional, complementary and integrative medicine not elsewhere classifiedInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 08, 2026
Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study.

|May 21, 2026
Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series.

|Feb 11, 2026
Dermatologic adverse events associated with amivantamab: A multicentre study.

Vasiliki Nikolaou, Ander Mayor, Vincent Sibaud

|Apr 26, 2021
Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance.

J M Busto-Leis, G Servera-Negre, A Mayor-Ibarguren

|Jul 04, 2020
Concurrent chilblains and retinal vasculitis in a child with COVID-19.

L Quintana-Castanedo, M Feito-Rodríguez, C Fernández-Alcalde

|May 23, 2020
Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report.

A Mayor-Ibarguren, M Feito-Rodriguez, L Quintana Castanedo

Pageof 2

Frequent Collaborators

2 joint publications

L Quintana-Castanedo

2 joint publications

Dimitra Koumaki

2 joint publications

Vincent Sibaud

2 joint publications

Zoe Apalla